iShares U.S. Medical Devices UCITS ETF (AMS:UMDV)
Netherlands · Delayed Price · Currency is EUR · Price in USD 5.45
+0.06 (1.13%)
Jun 26, 2026, 5:35 PM CET
-18.62% (1Y)
| Assets | 135.23M |
| Expense Ratio | 0.25% |
| PE Ratio | 25.87 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -18.62% |
| Volume | n/a |
| Open | 5.36 |
| Previous Close | 5.39 |
| Day's Range | 5.35 - 5.45 |
| 52-Week Low | 5.09 |
| 52-Week High | 7.02 |
| Beta | 0.76 |
| Holdings | 53 |
| Inception Date | Aug 3, 2020 |
About UMDV
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the Dow Jones U.S. Select Medical Equipment Capped 35/20 Index.
Asset Class Equity
Category Health Care
Region North America
Stock Exchange Euronext Amsterdam
Ticker Symbol UMDV
Provider iShares
Index Tracked Dow Jones U.S. Select Medical Equipment Capped 35/20 Index
Performance
UMDV had a total return of -18.62% in the past year, including dividends. Since the fund's inception, the average annual return has been 1.31%.
Top 10 Holdings
82.52% of assets| Name | Symbol | Weight |
|---|---|---|
| Abbott Laboratories | ABT | 16.73% |
| Intuitive Surgical, Inc. | ISRG | 15.60% |
| Stryker Corporation | SYK | 11.50% |
| Medtronic plc | MDT | 11.13% |
| Boston Scientific Corporation | BSX | 7.20% |
| Edwards Lifesciences Corporation | EW | 5.41% |
| IDEXX Laboratories, Inc. | IDXX | 4.71% |
| Becton, Dickinson and Company | BDX | 4.24% |
| GE HealthCare Technologies Inc. | GEHC | 3.02% |
| ResMed Inc. | RMD | 2.99% |